Travel Medicine and Infectious Disease
Volume 28, 2019, Pages 59-63
Performance of the point-of-care circulating cathodic antigen (POC-CCA) urine cassette test for follow-up after treatment of S. mansoni infection in Eritrean refugees (Article)
Neumayr A.* ,
Chernet A. ,
Sydow V. ,
Kling K. ,
Kuenzli E. ,
Marti H. ,
Paris D.H. ,
Nickel B. ,
Labhardt N.D.
-
a
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
b
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
c
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
d
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
e
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
f
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
g
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
h
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
-
i
Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Abstract
Background: Point-of-care circulating cathodic antigen (POC-CCA) urine cassette testing has become a popular approach to screen for Schistosoma infection. Since the test is also increasingly used for following-up of treatment success, we assessed the assay's diagnostic accuracy after praziquantel treatment of S. mansoni infection among Eritrean refugees in Switzerland. Methods: In our preceding study, 107 asymptomatic Eritrean refugees in Switzerland were screened for schistosomiasis by stool microscopy, serology, and POC-CCA urine testing. Individuals screened positive by any method were treated with praziquantel and invited for a follow-up visit, repeating the same diagnostic procedures one year after treatment. The POC-CCA baseline and follow-up results were analyzed against the ‘baseline microscopy positive cases’ (= the most reliably true positive cases) and the ‘baseline microscopy plus serology negative cases at baseline and follow-up’ (= the most reliably true negative cases). Results: Complete diagnostic baseline and follow-up sampling was available from 48 participants. Compared to most reliably true positive cases at baseline, POC-CCA testing had a sensitivity of 90%. Compared to most reliably true negative cases, POC-CCA testing had a specificity of 73.9%. Conclusion: We conclude that the POC-CCA urine test is valuable for screening but its use is not suitable for routine follow-up after treatment. © 2018
Author Keywords
Index Keywords
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053682685&doi=10.1016%2fj.tmaid.2018.09.004&partnerID=40&md5=ca9b5143c7cc148726be6858d5501b6b
DOI: 10.1016/j.tmaid.2018.09.004
ISSN: 14778939
Cited by: 3
Original Language: English